Items where Author is "Wilkinson, R.W."

LEYLAND, Rebecca, WATKINS, A., MULGREW, K.A., HOLOWECKYJ, N., BAMBER, L., TIGUE, N.J., OFFER, E., ANDREWS, J., YAN, L., MULLINS, S., OBERST, M.D., ULRICHSEN, J.C., LEINSTER, D.A., MCGLINCHEY, K., YOUNG, L., MORROW, M., HAMMOND, S.A., MALLINDER, P., HERATH, A., CHING LEOW, C., WILKINSON, R.W. and STEWART, R. (2017). A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy that Is Further Enhanced in Combination with an OX40 Agonist. Clinical Cancer Research, 23 (13), 3416-3427.

WILLIAMS, G.S., MISTRY, B., GUILLARD, S., ULRICHSEN, J.C., SANDERCOCK, A.M., WANG, J., GONZÁLEZ-MUÑOZ, A., PARMENTIER, J., BLACK, C., SODEN, J., FREETH, J., JOVANOVIC, J., LEYLAND, Rebecca, AL-LAMKI, R.S., LEISHMAN, A.J., RUST, S.J., STEWART, R., JERMUTUS, L., BRADLEY, J.R., BEDIAN, V., VALGE-ARCHER, V., MINTER, R. and WILKINSON, R.W. (2016). Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy. Oncotarget, 7 (42), 68278-68291.